Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.7K Sell
165
-11,865
-99% -$210K ﹤0.01% 418
2022
Q1
$247K Sell
12,030
-1,290
-10% -$28K 0.07% 281
2021
Q4
$337K Buy
13,320
+130
+1% +$3.1K 0.08% 244
2021
Q3
$292K Sell
13,190
-200
-1% -$4.19K 0.07% 293
2021
Q2
$279K Buy
13,390
+9,000
+205% +$182K 0.06% 306
2021
Q1
$93.1K Buy
+4,390
New +$92.7K 0.03% 430
2015
Q1
Sell
-1,240
Closed -$5.08K 555
2014
Q4
$5.08K Buy
+1,240
New +$4.89K ﹤0.01% 436

Other funds holding SONY

Exane Derivatives's SONY Position: Q2 2022 in Review

Exane Derivatives reduced its Sony (SONY) stake by 99% in Q2 2022, selling an estimated $210K and leaving 165 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

Exane Derivatives first reported a position in SONY in Q4 2014 and has held it in 7 quarters since. The position peaked at $337K in Q4 2021. 581 funds tracked by Wall St. Rank hold SONY as of Q2 2022.

  • Exane Derivatives held 165 shares of Sony worth $2.7K as of Q2 2022.
  • Exane Derivatives sold 11,865 Sony shares in Q2 2022, an estimated $210K.
  • Sony made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #418 holding.
  • Exane Derivatives first reported a position in Sony in Q4 2014 and has held it in 7 quarters since.
  • Exane Derivatives's Sony position peaked at $337K in Q4 2021.
  • 581 funds tracked by Wall St. Rank held Sony as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.